Pathobiological Insights into Neurological Involvement in Cobalamin C Deficiency

Abstract

Cobalamin C (Cbl-C) defects are inherited autosomal recessive disorders of vitamin B₁₂ (or cyanocobalamin [CNCbl]) metabolism. These defects are caused by mutations in the methylmalonic aciduria and homocystinuria Cbl-C type (MMACHC; MIM # 609831) gene located on chromosome 1p34.1, which catalyzes the reductive decyanation of CNCbl, thus impairing the biosynthesis of 5′-deoxyadenosylcobalamin, adenosylcobalamin, and methylcobalamin. This impairment results in methylmalonic acidemia [MMA; MIM # 277400] combined with hyperhomocysteinemia and hypomethioninemia. Clinically, Cbl-C defects are characterized by a constellation of systemic signs and symptoms, including neurological, cognitive, psychiatric, and thromboembolic events. Retinal phenotypes, including maculopathy, pigmentary retinopathy, and optic atrophy, are common in the early-onset form of the disease, but are rare in its adult-onset counterpart. Administration of hydroxocobalamin (OHCbl), betaine, and folinic acid represents main therapeutic approaches. No proven efficacy has been demonstrated for carnitine and dietary protein restrictions. Although early introduction of OHCbl is crucial, no standardized protocols regarding dose adjustment exist. Despite these measures, the long-term outcome is unsatisfactory especially in patients with early onset, who experience frequent progression of their neurological and ocular impairment. The unfavorable outcome suggests that a better understanding of the pathophysiology of the disease is needed to improve treatment protocols and to develop new therapeutic approaches.

Keywords

cobalamin C - vitamin B₁₂ - MMACHC gene

• References

• 1 Caterino M, Pastore A, Strozziero MG , et al. The proteome of cblC defect: in vivo elucidation of altered cellular pathways in humans. J Inherit Metab Dis 2015; 38 (5) 969-979
• 2 Biancheri R, Cerone R, Rossi A , et al. Early-onset cobalamin C/D deficiency: epilepsy and electroencephalographic features. Epilepsia 2002; 43 (6) 616-622
• 3 Pavone P, Spalice A, Polizzi A, Parisi P, Ruggieri M. Ohtahara syndrome with emphasis on recent genetic discovery. Brain Dev 2012; 34 (6) 459-468
• 4 Pavone P, Striano P, Falsaperla R, Pavone L, Ruggieri M. Infantile spasms syndrome, West syndrome and related phenotypes: what we know in 2013. Brain Dev 2014; 36 (9) 739-751
• 5 Longo D, Fariello G, Dionisi-Vici C , et al. MRI and 1H-MRS findings in early-onset cobalamin C/D defect. Neuropediatrics 2005; 36 (6) 366-372
• 6 Van der Knaap M, Valk J. Magnetic Resonance of Myelination and Myelin Disorders. 3rd ed. Berlin: Springer-Verlag; 2005
• 7 Patton N, Beatty S, Lloyd IC, Wraith JE. Optic atrophy in association with cobalamin C (cblC) disease. Ophthalmic Genet 2000; 21 (3) 151-154
• 8 Traboulsi EI, Silva JC, Geraghty MT, Maumenee IH, Valle D, Green WR. Ocular histopathologic characteristics of cobalamin C type vitamin B12 defect with methylmalonic aciduria and homocystinuria. Am J Ophthalmol 1992; 113 (3) 269-280
• 9 Thauvin-Robinet C, Roze E, Couvreur G , et al. The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum. J Neurol Neurosurg Psychiatry 2008; 79 (6) 725-728
• 10 Smith SE, Kinney HC, Swoboda KJ, Levy HL. Subacute combined degeneration of the spinal cord in cblC disorder despite treatment with B12. Mol Genet Metab 2006; 88 (2) 138-145
• 11 Martinelli D, Deodato F, Dionisi-Vici C. Cobalamin C defect: natural history, pathophysiology, and treatment. J Inherit Metab Dis 2011; 34 (1) 127-135
• 12 Wong A, Mok V, Fan YH, Lam WW, Liang KS, Wong KS. Hyperhomocysteinemia is associated with volumetric white matter change in patients with small vessel disease. J Neurol 2006; 253 (4) 441-447
• 13 Kölker S, Sauer SW, Hoffmann GF, Müller I, Morath MA, Okun JG. Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism. J Inherit Metab Dis 2008; 31 (2) 194-204
• 14 Scott JM, Dinn JJ, Wilson P, Weir DG. Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet 1981; 2 (8242) 334-337
• 15 Lee CC, Surtees R, Duchen LW. Distal motor axonopathy and central nervous system myelin vacuolation caused by cycloleucine, an inhibitor of methionine adenosyltransferase. Brain 1992; 115 (Pt 3) 935-955
• 16 Kruman II, Culmsee C, Chan SL , et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000; 20 (18) 6920-6926
• 17 Di Rocco A, Bottiglieri T, Werner P , et al. Abnormal cobalamin-dependent transmethylation in AIDS-associated myelopathy. Neurology 2002; 58 (5) 730-735
• 18 Longo N, Ardon O, Vanzo R, Schwartz E, Pasquali M. Disorders of creatine transport and metabolism. Am J Med Genet C Semin Med Genet 2011; 157C (1) 72-78
• 19 Bodamer OA, Sahoo T, Beaudet AL , et al. Creatine metabolism in combined methylmalonic aciduria and homocystinuria. Ann Neurol 2005; 57 (4) 557-560
• 20 Maestro de las Casas C, Epeldegui M, Tudela C, Varela-Moreiras G, Pérez-Miguelsanz J. High exogenous homocysteine modifies eye development in early chick embryos. Birth Defects Res A Clin Mol Teratol 2003; 67 (1) 35-40
• 21 Kikuchi M, Kashii S, Honda Y, Tamura Y, Kaneda K, Akaike A. Protective effects of methylcobalamin, a vitamin B12 analog, against glutamate-induced neurotoxicity in retinal cell culture. Invest Ophthalmol Vis Sci 1997; 38 (5) 848-854
• 22 Vidal-Alaball J, Butler CC, Cannings-John R , et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev 2005; 20 (3) CD004655
• 23 Dionisi-Vici C, Martinelli D, Ceravolo F, Boenzi S, Pastore A. Optimizing the dose of hydroxocobalamin in cobalamin C (cblC) defect. Mol Genet Metab 2013; 109 (4) 329-330
• 24 Spector R. Cerebrospinal fluid folate and the blood brain barrier. In: Botez M, Reynolds E, eds. Folic Acid in Neurology, Psychiatry, and Internal Medicine. New York, NY: Reven Press; 1979: 187-194
• 25 Smulders YM, Smith DE, Kok RM , et al. Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: a case for the methylfolate trap. Br J Haematol 2006; 132 (5) 623-629
• 26 Bartholomew DW, Batshaw ML, Allen RH , et al. Therapeutic approaches to cobalamin-C methylmalonic acidemia and homocystinuria. J Pediatr 1988; 112 (1) 32-39
• 27 Rosenblatt DS, Aspler AL, Shevell MI, Pletcher BA, Fenton WA, Seashore MR. Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC). J Inherit Metab Dis 1997; 20 (4) 528-538
• 28 Andersson HC, Marble M, Shapira E. Long-term outcome in treated combined methylmalonic acidemia and homocystinemia. Genet Med 1999; 1 (4) 146-150